Kustoff Introduces Bipartisan Legislation to Increase U.S. and Israel Cooperation on COVID-19 Medical Research
WASHINGTON, DC – Today, Reps. David Kustoff (R-TN), Chris Pappas (D-NH), Lance Gooden (R-TX), and Tom Suozzi (D-NY) introduced the Expanding Medical Partnerships with Israel to Lessen Dependence on China Act. The legislation authorizes a new partnership program to enhance cooperation between the United States and Israel to develop innovative approaches for treating and potentially curing COVID-19. In addition to this bill, Reps. Kustoff, Pappas, Gooden, Suozzi are also pushing for the inclusion of $12 million, which would be matched by Israel, to fund the new research partnership in any future legislation to address the impact of the COVID-19 pandemic.
“The United States and Israel are world leaders in the medical technology industry. It’s long past time we end our dependence on China and enhance our partnership with our great ally Israel to develop innovative medical technologies to treat and cure COVID-19. It’s in the benefit of not only our two countries, but also the rest of the world. I look forward to getting this bill passed and ensuring American and Israeli companies can work together to defeat this current pandemic,” said Rep. Kustoff